Since NF-κB activation is accompanied by tumor-favoring effects [25] and curcumin presents as a selective NF-κB inhibitor [29], we expected that curcumin might be able to minimize the negative effects induced by PIC, thereby resulting in an exclusive activation of the desired type I interferon pathway. This evidence concerns the gene NFKB1 and neoplasm.